Innovation in feasibility tools and data platforms has opened doors to new possibilities for clinical trial design and management.

As the year draws to a close, Outsourcing-Pharma caught up with some senior executives for a three-part series looking back on an eventful 2022, and look ahead to 2023.

Patient-centricity has become a buzzword in clinical trials, but many practical barriers still limit diversity and reduce participant satisfaction.

Mural Health Technologies, Inc., a new global provider of clinical trials technology, announced the launch of its new participant-facing technology platform, Mural Link at the CNS Summit in November.